Table 1:
Baseline clinical characteristics*
| Combined (n = 16) | IV rtPA (n = 13) | P Value | |
|---|---|---|---|
| Age (years, range) | 70 ± 8.8 (53–81) | 76 ± 10.2 (60–91) | .11 |
| Sex (male/female) | 11/5 | 6/7 | .27 |
| Baseline NIHSS score | 19 ± 2.2 | 16 ± 5.0 | .064 |
| Early CT sign | 4 (25%) | 4 (31%) | 1 |
| Lesion side (left/right) | 9/7 | 7/6 | 1 |
| Blood pressure: | |||
| Systolic (mm Hg) | 150 ± 20 | 153 ± 19 | .67 |
| Diastolic (mm Hg) | 83 ± 14 | 82 ± 13 | .86 |
| Blood glucose (mg/dL) | 136 ± 40 | 127 ± 31 | .51 |
| Stroke subtype: | |||
| Cardioembolic | 14 (87%) | 13 (100%) | |
| Atherothrombotic | 2 (13%) | 0 | |
| Lacunar/other | 0 | 0 | |
| Concomitant disease: | |||
| Hypertension | 9 (56%) | 6 (46%) | |
| Dyslipidemia | 3 (19%) | 2 (15%) | |
| Diabetes | 4 (25%) | 2 (15%) | |
| Atrial fibrillation | 13 (81%) | 10 (77%) | |
| Sick sinus syndrome | 0 | 1 (8%) | |
| Coronary heart disease | 2 (13%) | 1 (8%) | |
| Dilated cardiomyopathy | 1 (6%) | 0 | |
| Valvular heart disease | 1 (6%) | 3 (23%) |
Note:—IV indicates intravenous; rtPA, recombinant tissue plasminogen activator; NIHSS, National Institutes of Health Stroke Scale.
*
Data expressed as n (%) or mean ± SD.